Apollo and Oxford University enter drug discovery and development collaboration
The latest collaboration marks Apollo’s sixth agreement with a research institution
Read Moreby Jen Brogan | Jul 31, 2024 | News | 0
The latest collaboration marks Apollo’s sixth agreement with a research institution
Read Moreby Jen Brogan | May 24, 2024 | News | 0
Impacting more than 150,000 people in the UK, the lifelong autoimmune disease affects the brain and spinal cord
Read Moreby Jen Brogan | May 20, 2024 | News | 0
Globally affecting 4% of the population, autoimmune diseases mistakenly attack healthy cells, tissues and organs in the body
Read Moreby Jen Brogan | Dec 8, 2023 | News | 0
The project will explore the biology of human autoreactive plasma cells
Read Moreby Jen Brogan | Oct 11, 2023 | News | 0
The deal gives Kyowa access to a therapy for early-onset metachromatic leukodystrophy
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
